Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several
antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment …

With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …

PURPOSE To update the ASCO guideline on the recommended prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Colon Cancer focuses on systemic therapy options for the treatment of metastatic …

Chemotherapy induced peripheral neuropathy (CIPN) is a type of neuropathic pain that is a
major dose-limiting side-effect of potentially curative cancer chemotherapy treatment …

In terms of antinociceptive action, the main mode of action of magnesium involves its
antagonist action at the N-methyl-d-aspartate (NMDA) receptor, which prevents central …

Background Cisplatin and several related antineoplastic drugs used to treat many types of
solid tumours are neurotoxic, and most patients completing a full course of cisplatin …

The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical
management, perioperative treatment, posttreatment surveillance, management of recurrent …

Obesity, type 2 diabetes, arterial hypertension, decrease in immune response, cytokine
storm, endothelial dysfunction, and arrhythmias, which are frequent in COVID-19 patients …

Background Peripheral sensory neurotoxicity is a frequent adverse effect of oxaliplatin
therapy. Calcium and magnesium (Ca/Mg) infusions are frequently used as preventatives …